Collegium Pharmaceutical, Inc. (COLL)

NASDAQ: COLL · Real-Time Price · USD

Compare

45.36

+0.54 (1.20%)

At close: Jan 29, 2026, 4:00 PM EST

45.35

-0.01 (-0.02%)

After-hours: Jan 29, 2026, 4:20 PM EST

Collegium Pharmaceutical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	757.07	631.45	566.77	463.93	276.87	310.02	Upgrade
Revenue Growth (YoY)	26.34%	11.41%	22.17%	67.56%	-10.69%	4.49%	Upgrade
Cost of Revenue	89.55	83.53	79.72	118.19	59.07	69.5	Upgrade
Gross Profit	667.51	547.92	487.05	345.74	217.8	240.52	Upgrade
Selling, General & Admin	270.64	182.98	150.71	172.19	118.96	113.83	Upgrade
Research & Development	-	-	-	3.98	9.45	9.77	Upgrade
Amortization of Goodwill & Intangibles	221.89	165.3	145.76	131.47	67.18	60.68	Upgrade
Operating Expenses	492.53	348.29	296.47	307.64	195.59	184.28	Upgrade
Operating Income	174.99	199.63	190.58	38.11	22.21	56.23	Upgrade
Interest Expense	-85.67	-73.97	-83.34	-63.21	-21.01	-28.88	Upgrade
Interest & Investment Income	9.54	13.98	15.62	1.05	0.01	0.23	Upgrade
EBT Excluding Unusual Items	98.85	139.63	122.85	-24.06	1.2	27.58	Upgrade
Merger & Restructuring Charges	-17.62	-29.6	-15.12	-	-4.58	-	Upgrade
Asset Writedown	-	-	-	-4.79	-	-	Upgrade
Legal Settlements	-3.06	-	-8.5	-	-	-	Upgrade
Other Unusual Items	2.68	-11.47	-23.5	-	-	-	Upgrade
Pretax Income	80.85	98.57	75.73	-28.85	-3.37	27.58	Upgrade
Income Tax Expense	22.41	29.38	27.58	-3.85	-74.89	0.83	Upgrade
Net Income	58.44	69.19	48.16	-25	71.52	26.75	Upgrade
Net Income to Common	58.44	69.19	48.16	-25	71.52	26.75	Upgrade
Net Income Growth	-34.03%	43.68%	-	-	167.33%	-	Upgrade
Shares Outstanding (Basic)	32	32	34	34	35	34	Upgrade
Shares Outstanding (Diluted)	40	40	42	34	41	35	Upgrade
Shares Change (YoY)	-13.26%	-3.26%	23.53%	-17.58%	16.77%	5.07%	Upgrade
EPS (Basic)	1.84	2.14	1.43	-0.74	2.05	0.78	Upgrade
EPS (Diluted)	1.63	1.86	1.29	-0.74	1.86	0.76	Upgrade
EPS Growth	-24.84%	43.56%	-	-	144.25%	-	Upgrade
Free Cash Flow	289.3	203.33	274.29	122.61	101.61	88.4	Upgrade
Free Cash Flow Per Share	7.29	5.03	6.56	3.62	2.48	2.52	Upgrade
Gross Margin	88.17%	86.77%	85.93%	74.52%	78.66%	77.58%	Upgrade
Operating Margin	23.11%	31.61%	33.63%	8.21%	8.02%	18.14%	Upgrade
Profit Margin	7.72%	10.96%	8.50%	-5.39%	25.83%	8.63%	Upgrade
Free Cash Flow Margin	38.21%	32.20%	48.39%	26.43%	36.70%	28.51%	Upgrade
EBITDA	401.18	368.79	339.83	172.26	91.12	117.78	Upgrade
EBITDA Margin	52.99%	58.40%	59.96%	37.13%	32.91%	37.99%	Upgrade
D&A For EBITDA	226.19	169.16	149.26	134.15	68.92	61.55	Upgrade
EBIT	174.99	199.63	190.58	38.11	22.21	56.23	Upgrade
EBIT Margin	23.11%	31.61%	33.63%	8.21%	8.02%	18.14%	Upgrade
Effective Tax Rate	27.72%	29.80%	36.41%	-	-	3.01%	Upgrade
Advertising Expenses	-	10.66	7.41	11.74	4.19	5.37	Upgrade

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q